Biorestorative Therapies (BRTX)
(Delayed Data from NSDQ)
$1.69 USD
+0.19 (12.67%)
Updated Sep 13, 2024 03:55 PM ET
After-Market: $1.67 -0.02 (-1.18%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/11/2024
Time: -- |
9/2024 | $-0.36 | 0.00% |
Earnings Summary
For their last quarter, Biorestorative Therapies (BRTX) reported earnings of -$0.50 per share, beating the Zacks Consensus Estimate of $-0.56 per share. This reflects a positive earnings surprise of 10.71%. Look out for BRTX's next earnings release expected on November 11, 2024. For the next earning release, we expect the company to report earnings of -$0.36 per share, reflecting a year-over-year increase of 43.75%.
Earnings History
Price & Consensus
Zacks News for BRTX
TScan Therapeutics, Inc. (TCRX) Reports Q2 Loss, Lags Revenue Estimates
BRTX: What are Zacks experts saying now?
Zacks Private Portfolio Services